Rituximab therapy for refractory scleritis: Results of a phase I/II dose-ranging, randomized, clinical trial

Eric B. Suhler, Lyndell L. Lim, Robert M. Beardsley, Tracy R. Giles, Sirichai Pasadhika, Shelly T. Lee, Alexandre De Saint Sardos, Nicholas J. Butler, Justine R. Smith, James T. Rosenbaum

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Fingerprint Dive into the research topics of 'Rituximab therapy for refractory scleritis: Results of a phase I/II dose-ranging, randomized, clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences